← All peptides
Hormones & TRT
Clinical

Testosterone Cypionate

Also known as: Test Cyp, Depo-Testosterone

A long-acting injectable testosterone ester used clinically for testosterone replacement therapy (TRT) in men with diagnosed hypogonadism. Prescription medication.

Last updated

Mechanism of Action

Testosterone cypionate is an esterified form of the endogenous androgen testosterone. After intramuscular or subcutaneous injection it is slowly released and cleaved to free testosterone, which binds the androgen receptor to drive secondary sexual characteristics, muscle protein synthesis, bone density, erythropoiesis, libido, and mood. The cypionate ester extends the half-life so dosing every 3.5-7 days maintains stable serum levels.

Half-life
~8 days (cypionate ester)
Administration Routes
Intramuscular, Subcutaneous
Research Status
Clinical

Reported Benefits

  • Restores serum testosterone in diagnosed hypogonadism
  • Supports libido, energy, mood, and cognition when levels are low
  • Preserves lean mass and bone mineral density

Potential Side Effects

  • Erythrocytosis (elevated hematocrit)
  • Estrogen-related effects (water retention, gynecomastia) via aromatization
  • Testicular atrophy and suppressed fertility
  • Acne, oily skin

Common Dosing

TRT protocols reported in the literature are typically 100-200 mg per week, often split into two injections, titrated to trough serum testosterone and symptoms. Dosing must be individualized and supervised by a physician.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Prostate or breast cancer
  • Untreated erythrocytosis
  • Pregnancy (contraindicated) and men seeking fertility without adjuncts
  • Uncontrolled cardiovascular disease — use only under medical supervision
  • Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects

    2018

    View
  • Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate

    2022

    View
  • Comparison of Hematocrit Change in Testosterone-deficient Men Treated With Intranasal Testosterone Gel vs Intramuscular Testosterone Cypionate: A Randomized Clinical Trial

    2023

    View
  • Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline

    2018

    View

No. It is a steroid hormone ester, included here because it is commonly tracked alongside peptides in a personal protocol. It is a prescription medication and should only be used under medical supervision.

Historically intramuscular; many modern TRT protocols use small subcutaneous injections. Route and dose are determined by a prescribing clinician.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.